Roflumilast (APTA 2217) is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide
Molecular Weight:
403.21
CAS Number:
[162401-32-3]
Formula:
C17H14Cl2F2N2O3
Target:
RSV|||PDE
* VAT and and shipping costs not included. Errors and price changes excepted